Antibody-based biosensor to detect oncogenic splicing factor Sam68 for the diagnosis of lung cancer
- 9 July 2020
- journal article
- research article
- Published by Springer Nature in Biotechnology Letters
- Vol. 42 (12) , 2501-2509
Abstract
Objective The present work aimed to investigate the potential utility of Sam68 protein as a prognostic marker in lung cancer. Then an electrochemical immunosensor is fabricated that is sufficiently sensitive to detect Sam68. Results Analysis of stage-specific Lung cancer microarray data shows that differential expression of Sam68 is associated with cancer stage and monotonically increases from early tumor stage to advanced metastatic stage. Moreover, the higher expression of Sam68 results in reduced survival of lung cancer patients. Based on these observations, an electrochemical immunosensor was developed for the quantification of Sam68 protein. The target protein was captured by the Anti-Sam68 antibody that was immobilized on the modified Glassy carbon electrode. The stepwise assembly process was characterized by cyclic voltammetry and electrochemical impedance spectroscopy. This fabricated immunosensor displayed good analytical performance in comparison to commercial ELISA kit with good sensitivity, lower detection limit (LOD) of 10.5 pg mL−1, and wide linear detection range from 1 to 5 μg mL−1. This method was validated with satisfactory detection of Sam68 protein in lung adenocarcinoma cell line, NCI-H23. Besides, spike and recovery assay reconfirm that the sensor can precisely quantify Sam68 protein in a complex physiological sample. Conclusion We conclude Sam68 as a valuable prognostic biomarker for early detection of lung cancer. Moreover, we report the first study on the development of an electrochemical immunosensor for the detection of Sam68. The fabricated immunosensor exhibit excellent analytical performance, which can accurately predict the lung cancer patient pathological state.Keywords
Funding Information
- Anusandhan National Research Foundation
This publication has 28 references indexed in Scilit:
- Fabrication of an immunosensor for quantitative detection of breast cancer biomarker UBE2CRSC Advances, 2019
- A needle-type glucose biosensor based on PANI nanofibers and PU/E-PU membrane for long-term invasive continuous monitoringBiosensors and Bioelectronics, 2017
- Protein Sam68 regulates the alternative splicing of survivin DEx3Journal of Biological Chemistry, 2017
- Sam68 is Overexpressed in Epithelial Ovarian Cancer and Promotes Tumor Cell ProliferationMedical Science Monitor, 2016
- Sam68 reduces cisplatin-induced apoptosis in tongue carcinomaJournal of Experimental & Clinical Cancer Research, 2016
- SAM68: Signal Transduction and RNA Metabolism in Human CancerBioMed Research International, 2015
- The RNA-binding protein Sam68 is a multifunctional player in human cancerEndocrine-Related Cancer, 2011
- Recent advances in polyaniline based biosensorsBiosensors and Bioelectronics, 2011
- The role of the RNA‐binding protein Sam68 in mammary tumourigenesisThe Journal of Pathology, 2010
- The RNA-binding protein Sam68 contributes to proliferation and survival of human prostate cancer cellsOncogene, 2007